ArticleCureus2026
Declining Economic Burden of Coronary Atherosclerosis Relative to the United States Economic Output and Healthcare Sector Growth.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Coronary atherosclerosis remains a leading cause of ischemic heart disease and cardiovascular morbidity and mortality. While its clinical burden is well described, less is known about how its economic burden, defined using absolute expenditures and relative measures such as share of economic output, has changed over time. Objective To evaluate national trends in expenditures and utilization for coronary atherosclerosis and assess changes in its economic burden relative to the overall United States (US) economic output and healthcare sector growth. Methods National expenditure data from 2000 to 2021 were obtained from the National Income and Product Accounts (NIPA). Disease-specific spending was benchmarked against the total US gross output, used as a proxy for overall economic activity rather than direct gross domestic product (GDP) estimates, and the Healthcare and Social Assistance sector output. Outcomes included per capita spending, episode volume defined as aggregated counts of condition-specific healthcare encounters, total expenditures based on constant-dollar inflation-adjusted NIPA estimates, uncontrolled expenditures defined as non-population-adjusted totals, and cost per case. Temporal trends were evaluated using univariate linear regression. Results Between 2000 and 2021, per capita spending declined from $90.70 to $64.54 (-28.8%), with an average annual decrease of $1.86 (p<0.0001). Episode volume decreased from $13.34 million to $11.22 million (-15.9%), corresponding to an annual reduction of 136,874 episodes (p<0.0001). Total expenditures declined from $255.9 billion to $213.6 billion (-16.6%), with an annual decrease of $381.6 million (p=0.0003). Uncontrolled expenditures declined from $196.9 billion to $173.7 billion (-11.8%) (p=0.0004). Cost per case changed minimally, decreasing from $1,918 to $1,904 (less than 1% decline; p=0.026). Spending as a share of the total US economic output declined from 0.17% to 0.06% (p<0.001). Conclusion In this national, longitudinal analysis, the economic burden of coronary atherosclerosis declined across multiple absolute measures and relative benchmarks. These findings reflect reductions in spending and utilization over time; however, given the observational and aggregate nature of the data, underlying drivers cannot be determined. Macroeconomic benchmarking of disease-specific expenditures may provide a useful framework for evaluating long-term trends in healthcare spending.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.